Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite Vision Enhancement System, 20 ga recall — FDA Z-3267-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Recall history in this database
Classification mix: Class II: 17, Class III: 3.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite Vision Enhancement System, 23 ga recall — FDA Z-3269-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite Vision Enhancement System, 23 ga recall — FDA Z-3270-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite Vision Enhancement System, 25 ga recall — FDA Z-3273-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite 23 GA Vit Cutter, Model BL5627, 7500 cpm, packaged in sterile recall — FDA Z-3268-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite 20 GA Vit Cutter, Model BL5626, 7500 cpm, packaged in sterile recall — FDA Z-3265-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite Vision Enhancement System, 23 ga recall — FDA Z-3275-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite Vision Enhancement System, 20 ga recall — FDA Z-3266-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite Vision Enhancement System, 25 ga recall — FDA Z-3277-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite 25 GA Vit Cutter, Model BL5628, 7500 cpm, packaged in sterile recall — FDA Z-3271-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite Vision Enhancement System, 25 ga recall — FDA Z-3276-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite Vision Enhancement System, 25 ga recall — FDA Z-3272-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
Medical DeviceOct 3, 2018
Bausch + Lomb Stellaris Elite Vision Enhancement System, 23 ga recall — FDA Z-3274-2018
The back cap separates from the body of the vitrectomy cutter.
Class IIFDA: TerminatedBausch & Lomb Inc.
DrugJun 21, 2017
Bausch & Lomb NasalCrom (cromolyn sodium) Nasal Spray, USP, 5.2 mg per spray, 200 metered recall — FDA D-0899-2017
CGMP Deviations: Possibility of the presence of microbial contamination in the water used to manufacture this product lot.
Class IIFDA: TerminatedBausch & Lomb, Inc.
DrugFeb 3, 2016
Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1% recall — FDA D-0645-2016
Labeling: Incorrect or Missing Package Insert: Package insert is missing updates compared with reference drug insert.
Class IIIFDA: TerminatedBausch & Lomb, Inc.
DrugFeb 3, 2016
Tropicamide Ophthalmic Solution USP, 0.5% recall — FDA D-0646-2016
Labeling: Incorrect or Missing Package Insert: Package insert is missing updates compared with reference drug insert.
Class IIIFDA: TerminatedBausch & Lomb, Inc.
DrugFeb 3, 2016
Tropicamide Ophthalmic Solution USP, 1% recall — FDA D-0647-2016
Labeling: Incorrect or Missing Package Insert: Package insert is missing updates compared with reference drug insert.
Class IIIFDA: TerminatedBausch & Lomb, Inc.
DrugJul 2, 2014
Bausch & Lomb Sodium Chloride Hypertonicity Ophthalmic Ointment, 5%, 1/8 oz. (3.5 g) tube recall — FDA D-1411-2014
Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.
Class IIFDA: TerminatedBausch & Lomb, Inc.
DrugJul 2, 2014
Muro 128 (sodium chloride) hypertonicity ophthalmic ointment, 5% recall — FDA D-1410-2014
Crystallization: Crystal precipitate formation and an increase in the number of complaints associated with a gritty, sand-like feeling in the eye.
Class IIFDA: TerminatedBausch & Lomb, Inc.
DrugJun 20, 2012
Bausch & Lomb Murocel (methylcellulose) Lubricant Opthalmic Solution (USP, 1%), 15 mL recall — FDA D-1370-2012
Lack of Assurance of Sterility: Bausch & Lomb, Inc. is recalling 7 Lots of Murocel Methylcellulose Lubricant Opthalmic Solution 1% (15 mL). Product was found to be OOS for Antimicrobial…
Class IIFDA: TerminatedBausch & Lomb, Inc.
Understanding this recall history
This page summarizes recall records in which the official source identifies Bausch & Lomb, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.